These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 729732)

  • 1. Effect of non-steroidal anti-inflammatory drugs of Moloney sarcoma virus inoculated mice.
    Inglot AD; Oleszak E
    Experientia; 1978 Dec; 34(12):1615-7. PubMed ID: 729732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of Moloney sarcoma virus immunity following sensitization with attenuated virus.
    Wood GW
    Cancer Res; 1976 Dec; 36(12):4552-7. PubMed ID: 1000500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of anti-mouse type-1 interferon globulin on the evolution of Moloney sarcoma virus induced disease in mice.
    Inglot AD; Inglot O; Zóltowska A; Oleszak E
    Int J Cancer; 1979 Oct; 24(4):445-9. PubMed ID: 316806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor induction by murine sarcoma virus in AKR and C58 mice. Reduction of tumor regression associated with appearance of Gross leukemia virus pseudotypes.
    Chieco-Bianchi L; Colombatti A; Collavo D; Sendo F; Aoki T; Fischinger PJ
    J Exp Med; 1974 Nov; 140(5):1162-79. PubMed ID: 4608945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization against primary, transplanted and spontaneous murine leukaemia using a live Moloney sarcoma virus vaccine.
    Mayer AM; Basombrio MA; Pasqualini CD
    Br J Cancer; 1980 Jun; 41(6):966-75. PubMed ID: 6252923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temperature-sensitive tumorigenicity of cells transformed by a mutant of Moloney sarcoma virus.
    Klarlund JK; Forchhammer J
    Proc Natl Acad Sci U S A; 1980 Mar; 77(3):1501-5. PubMed ID: 6929500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet-derived growth factor (PDGF) enhances the growth of Moloney sarcoma virus-induced tumors in mice.
    Inglot AD; Inglot O
    Arch Immunol Ther Exp (Warsz); 1981; 29(4):431-7. PubMed ID: 7332446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific immunotherapy combined with whole body irradiation of BALB/c mice bearing Moloney murine sarcoma virus-induced primary tumors.
    Kimura H; Yamaguchi Y; Fujisawa T
    Gan; 1982 Jun; 73(3):446-53. PubMed ID: 6751920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Murine sarcoma virus pseudotypes used as immunogens against viral and chemical oncogenesis.
    Basombrío MA; Mayer AM; Pasqualini CD
    Cancer Res; 1977 Jun; 37(6):1768-76. PubMed ID: 192461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of anti-interferon serum on growth and regression of Moloney sarcoma virus induced tumours in mice.
    Inglot AD; Oleszak E; Inglot O
    Acta Biol Med Ger; 1979; 38(5-6):829-35. PubMed ID: 525154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro studies of cell-mediated immunity to Moloney murine leukemia virus and Moloney leukemia-associated surface antigens.
    Ng AK; Ames RS; McIntire RK; Herberman RB
    Cancer Res; 1979 Dec; 39(12):4887-93. PubMed ID: 387218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro cytotoxicity studies of murine sarcoma virus-induced immunity in mice.
    Lavrin DH; Herberman RB; Nunn M; Soares N
    J Natl Cancer Inst; 1973 Nov; 51(5):1497-508. PubMed ID: 4762933
    [No Abstract]   [Full Text] [Related]  

  • 13. [Factors regulating the spontaneous regression of primary tumors induced by murine sarcoma virus, Moloney strain, in mice (BALB-c-Cb-Se). I. Age at treatment and virus doses].
    Ribacchi R; Giraldo G
    Lav Ist Anat Istol Patol Univ Studi Perugia; 1967; 27(3):167-76. PubMed ID: 5605880
    [No Abstract]   [Full Text] [Related]  

  • 14. Tumour regression and relapse in mice inoculated with murine sarcoma virus (Moloney).
    Perk K; Russell E; Smith KL; Moloney JB
    Lab Anim; 1973 Sep; 7(3):255-63. PubMed ID: 4795193
    [No Abstract]   [Full Text] [Related]  

  • 15. Distribution of in vitro-stimulated immune lymphocytes in mice bearing Moloney murine sarcoma virus-induced primary tumor.
    Kimura H; Yamaguchi Y
    Gan; 1981 Feb; 72(1):72-80. PubMed ID: 7274651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T lymphocyte tolerance and early appearance of virus-induced cell surface antigens in Moloney-murine leukemia virus neonatally injected mice.
    Collavo D; Zanovello P; Biasi G; Chieco-Bianchi L
    J Immunol; 1981 Jan; 126(1):187-93. PubMed ID: 6969741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential disease restriction of Moloney and Friend murine leukemia viruses by the mouse Rmcf gene is governed by the viral long terminal repeat.
    Brightman BK; Li QX; Trepp DJ; Fan H
    J Exp Med; 1991 Aug; 174(2):389-96. PubMed ID: 1856627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of recombinant human interleukin 2 on the growth of a BALB/c sarcoma induced by Moloney murine sarcoma virus.
    Mitsunaga S; Kimura H; Yamaguchi Y; Mikata A
    Jpn J Cancer Res; 1988 Aug; 79(8):965-72. PubMed ID: 3141331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T lymphocyte requirement for MSV tumour prevention or regression.
    Collavo D; Colombatti A; Chieco-Bianchi L
    Nature; 1974 May; 249(453):169-70. PubMed ID: 4545519
    [No Abstract]   [Full Text] [Related]  

  • 20. Influence of Toxoplasma on manifestations of Moloney virus infections.
    McLeod R; Estes RG; Cohen H
    Trans R Soc Trop Med Hyg; 1985; 79(6):781-7. PubMed ID: 2938310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.